Free Trial

Jason Wittes Analyst Performance

Managing Director at Roth Mkm

Jason Wittes is a stock analyst at Roth Mkm focused in the medical sector, covering 21 publicly traded companies. Over the past year, Jason Wittes has issued 6 stock ratings, including strong buy and buy recommendations. While full access to Jason Wittes' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason Wittes' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
75 Last 11 Years
Buy Recommendations
78.38% 58 Buy Ratings
Companies Covered
21 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy2.7%2 ratings
Buy75.7%56 ratings
Hold16.2%12 ratings
Sell5.4%4 ratings

Out of 74 total stock ratings issued by Jason Wittes at Roth Mkm, the majority (75.7%) have been Buy recommendations, followed by 16.2% Hold, 5.4% Sell, and 2.7% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
61.9% of companies on NASDAQ
13 companies
NYSE
28.6% of companies on NYSE
6 companies
NYSEAMERICAN
4.8% of companies on NYSEAMERICAN
1 company
OTCMKTS
4.8% of companies on OTCMKTS
1 company

Jason Wittes, an analyst at Roth Mkm, currently covers 21 companies listed on NASDAQ, NYSE, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
20 companies
95.2%
Manufacturing
1 company
4.8%

Jason Wittes of Roth Mkm specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
7 companies
33.3%
MED PRODUCTS
6 companies
28.6%
MED - BIOMED/GENE
4 companies
19.0%
MED - DRUGS
2 companies
9.5%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
1 company
4.8%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
4.8%

Jason Wittes' Ratings History at Roth Mkm

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
CapsoVision, Inc. stock logo
CV
CapsoVision
11/4/2025Set Price Target$4.78$7.00
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
11/4/2025Initiated Coverage$8.62$30.00Buy
CapsoVision, Inc. stock logo
CV
CapsoVision
11/4/2025Upgrade$4.59Strong-Buy
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
9/4/2025Initiated Coverage$10.88$40.00Buy
CapsoVision, Inc. stock logo
CV
CapsoVision
7/28/2025Set Price Target$4.00$6.00Buy
CapsoVision, Inc. stock logo
CV
CapsoVision
7/28/2025Upgrade$4.35$6.00Strong-Buy
Stryker Corporation stock logo
SYK
Stryker
5/2/2025Boost Price Target$377.63$456.00Buy
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
3/21/2025Reiterated Rating$3.17$16.00Buy
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
3/18/2025Boost Price Target$3.62$5.40Buy
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
3/11/2025Reiterated Rating$1.75$16.00Buy
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2/26/2025Reiterated Rating$17.07$22.00Buy
iRadimed Corporation stock logo
IRMD
iRadimed
2/14/2025Reiterated Rating$55.53$72.00Buy
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
1/24/2025Reiterated Rating$5.17$11.00Buy